Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72804 record(s)

Req # A-2019-001366

Adverse Reaction Report (AER). Report number: E2B_02119211.

Organization: Health Canada

29 page(s)
January 2021

Req # A-2019-001432

Adverse Reaction Reports (AERs). Report numbers: E2B_01884366, E2B_02166710, E2B_01756457,E2B_01869180, E2B_01774097, E2B_01859202, E2B_01871242, E2B_01912704, E2B_01922213 E2B_01924771.

Organization: Health Canada

123 page(s)
January 2021

Req # A-2019-001548

Adverse Reaction Report (AER). Report number: E2B_02763703.

Organization: Health Canada

6 page(s)
January 2021

Req # A-2019-001863

Adverse Reaction Report (AER) for DEXILANT. Report numbers: E2B_02819319. AERs for ENTYVIO: E2B_02862257, E2B_02839118, 000731529, 000731158, E2B_02854153. AERs for VEDOLIZUMAB: E2B_02822017, E2B_02853524, E2B_02818273, E2B_02858723, E2B_02862064…

Organization: Health Canada

852 page(s)
January 2021

Req # A-2019-001997

Adverse Reaction Reports (AERs). Report numbers: 000723590, E2B_02394614, E2B_02221418, E2B_02313629, E2B_02313836, E2B_02313846, E2B_02313847, E2B_02388681, E2B_02398777, 000719561, 000721513, 000722240, E2B_02191232, E2B_02308896, E2B_023156424.

Organization: Health Canada

162 page(s)
January 2021

Req # A-2019-002011

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-100222-959.

Organization: Health Canada

5 page(s)
January 2021

Req # A-2020-000092

Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02729184, E2B_02729251, E2B_02729430, E2B_02729442, E2B_02813060, E2B_02729474, E2B_02729483, E2B_02730157, E2B_02730689, E2B_02730879, E2B_02732254, E2B_02745952,…

Organization: Health Canada

137 page(s)
January 2021

Req # A-2020-000115

Adverse Reaction Report (AER). Report number: E2B_02677382.

Organization: Health Canada

8 page(s)
January 2021

Req # A-2020-000135

Adverse Reaction Reports (AERs). Report numbers: E2B_02923798, E2B_02932860, E2B_02936877, E2B_02936939.

Organization: Health Canada

99 page(s)
January 2021

Req # A-2020-000143

Adverse Reaction Reports (AERs). Report numbers: E2B_02967245, E2B_02967381, E2B_02969820, E2B_02969837.

Organization: Health Canada

68 page(s)
January 2021
Date modified: